Skip to main content

SECONDARY HYPERTROPHIC OSTEOARTHROPATHY

Tracking # 20-815157

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

HYPERTROPHIC OSTEOARTHROPATHY (HOA) IS MAINLY CAUSED BY MAINLY FIBROVASCULAR PROLIFERATION. IT IS CHARACTERIZED BY A COMBINATION OF CLINICAL FINDINGS, INCLUDING SEVERE DISABLING ARTHRALGIA AND ARTHRITIS, DIGITAL CLUBBING, AND PERIOSTOSIS OF TUBULAR BONES WITH OR WITHOUT SYNOVIAL EFFUSION. IT CAN OCCUR AS AN AUTOSOMAL DOMINANT CONDITION CALLED PACHYDERMOPERIOSTOSIS, BUT MORE COMMONLY, IT OCCURS AS A SECONDARY MANIFESTATION OF A CHRONIC PULMONARY OR EXTRAPULMONARY DISEASE OR MALIGNANCY. THIS ACTIVITY OUTLINES THE EVALUATION AND TREATMENT OF HYPERTROPHIC OSTEOARTHROPATHY AND REVIEWS THE INTERPROFESSIONAL TEAM'S ROLE IN CARING FOR PATIENTS WITH THIS CONDITION.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1.25h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1.25h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1.25h AMA Category I

Physician Assistant

1.25h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1.25h AMA Category I